Nedira Salzman-Frenkel.
Corporate Officer/Principal at NEUROSENSE THERAPEUTICS LTD.
Nedira Salzman-Frenkel. active positions
| Companies | Position | Start | End |
|---|---|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Corporate Officer/Principal | 01/03/2022 | - |
Career history of Nedira Salzman-Frenkel.
Former positions of Nedira Salzman-Frenkel.
| Companies | Position | Start | End |
|---|---|---|---|
Radikal Therapeutics, Inc.
 Radikal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Radikal Therapeutics, Inc. develops transformative pharmaceuticals of bifunctional edox-based small molecules. The company was founded by Andrew L. Salzman and is headquartered in West Tisbury, MA. | Chief Executive Officer | 01/02/2017 | 01/10/2021 |
Training of Nedira Salzman-Frenkel.
| Ben-Gurion University of the Negev | Undergraduate Degree |
| The Hebrew University of Jerusalem | Graduate Degree |
| Recanati School of Business Administration | Masters Business Admin |
Statistics
International
| Israel | 5 |
| United States | 2 |
Operational
| Chief Executive Officer | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 4 |
| Commercial Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Radikal Therapeutics, Inc.
Radikal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Radikal Therapeutics, Inc. develops transformative pharmaceuticals of bifunctional edox-based small molecules. The company was founded by Andrew L. Salzman and is headquartered in West Tisbury, MA. | Commercial Services |
